Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant disorder characterized by ataxia, epilepsy and anticipation. A large expansion of the ATTCT repeat in intron 9 of the SCA10 gene encoding the E46L protein is the mutation responsible for this disease. The mechanism by which the expansion mutation leads to the disease phenotype is unknown. The goal of this project is to elucidate the pathogenic mechanism of SCA10. The long-term goal is to develop a rational therapy for SCA10 based on the pathogenic mechanism. The central hypothesis is that the major pathogenic mechanism of SCA10 is due to the disruption of the normal cellular function of polyprimidine tract binding proteins (PTBs) by the large expanded AUUCU repeat in the E46L RNA. This hypothesis is based on preliminary data that (i) SCA10 cells do not show altered levels of E46L mRNA and protein, (ii) loss of function of the E46L protein does not lead to a SCA10-like phenotype in mice, (iii), expanded ATTCT repeats are transcribed and accumulated in nuclear foci, and (iv) three species of PTBs (PTB, nPTB and hnRNP K) bind to AUUCU repeats in vitro and at least one (hnRNP K) co-localizes in the nuclear foci in cells derived from an SCA10 patient. The following two specific aims will be used to test our hypothesis.
Specific Aim 1 is to demonstrate that the transcript with an expanded AUUCU repeat gains toxic functions by binding and perturbing the function of PTBs in SCA10 cells. It is expected that (a) there is a detectable level of the expanded AUUCU repeat in SCA10 cells, and (b) expanded AUUCU repeats in SCA10 cells bind to PTBs and alter the cellular functions of PTBs.
Specific Aim 2 is to establish genetic mouse models of SCA10.
Aim 2 will be accomplished by (a) identifying the SCA10-like phenotype in the transgenic mice that express expanded AUUCU repeats, and (b) establishing genetic mouse models of SCA10 that lack the Hnrpk gene encoding hnRNP K and the Ptbp2 gene encoding the brain-specific nPTB. Transgenic mice expressing expanded AUUCU repeats are expected to exhibit an SCA10-like phenotype by the RNA-mediated gain of function through deficiency of these PTBs. Elucidating the disease mechanism of SCA10 is innovative because SCA10 is the only human disease known to be caused by an expansion of a pentanucleotide repeat. Establishing the mechanism in SCA10 will fill the current gap of knowledge and facilitate the development of rational therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS041547-09
Application #
7576918
Study Section
Special Emphasis Panel (ZRG1-CDIN-D (01))
Program Officer
Gwinn, Katrina
Project Start
2006-05-01
Project End
2010-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
9
Fiscal Year
2009
Total Cost
$329,897
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Neurology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
McFarland, Karen N; Liu, Jilin; Landrian, Ivette et al. (2015) SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS One 10:e0135906
Baizabal-Carvallo, J F; Xia, G; Botros, P et al. (2015) Bolivian kindred with combined spinocerebellar ataxia types 2 and 10. Acta Neurol Scand 132:139-42
McFarland, Karen N; Liu, Jilin; Landrian, Ivette et al. (2014) Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures. Neurogenetics 15:59-64
Bushara, Khalaf; Bower, Matthew; Liu, Jilin et al. (2013) Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS One 8:e81342
Xia, Guangbin; McFarland, Karen N; Wang, Kang et al. (2013) Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10. J Neurol Neurosurg Psychiatry 84:1409-11
Moro, Adriana; Munhoz, Renato P; Raskin, Salmo et al. (2013) Acute onset of cerebellar ataxia in a spinocerebellar ataxia type 10 patient after use of steroids. Arq Neuropsiquiatr 71:66
McFarland, Karen N; Liu, Jilin; Landrian, Ivette et al. (2013) Paradoxical effects of repeat interruptions on spinocerebellar ataxia type 10 expansions and repeat instability. Eur J Hum Genet 21:1272-6
Teive, Helio A G; Munhoz, Renato P; Arruda, Walter O et al. (2012) Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families. Clinics (Sao Paulo) 67:443-9
White, Misti; Xia, Guangbin; Gao, Rui et al. (2012) Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: a toxic RNA gain-of-function model. J Neurosci Res 90:706-14
McFarland, Karen N; Ashizawa, Tetsuo (2012) Transgenic models of spinocerebellar ataxia type 10: modeling a repeat expansion disorder. Genes (Basel) 3:481-91

Showing the most recent 10 out of 40 publications